Moreover, SLE patients with active disease (SLEDIA ≥ 10) had higher ET-1 levels compared to patients with less active disease (SLEDIA < 10) (P < 0.001, Fig. 1E). This evidence concerns the gene EDN1 and systemic lupus erythematosus.